Novartis
Novartis' internal document search platform, DMS DocFinder, was being discontinued due to technical limitations. The company needed a new, user-friendly solution to streamline document access for employees across departments, especially for SOPs (Standard Operating Procedures).
As the Senior Product Designer, I led the entire research and product design initiative, engaging with stakeholders, facilitating workshops, and ensuring alignment between user needs and technical feasibility. The goal was to deliver a new SOP document search platform that significantly improved document retrieval for Novartis employees.
Role
Senior Product Designer
Led the design process, from research through to implementation. Conducted user interviews, facilitated workshops, and developed prototypes. Worked closely with stakeholders and the development team.
Team
Luca Fiorentini — UX Designer
Aleksandar Cojic — Design Lead

This project aimed to replace Novartis' outdated document search platform, which had been decommissioned due to technical limitations. A Proof of Concept (POC) had already been developed by the technical team as an initial exploration, and it served as a foundation for our design efforts.
However, the POC highlighted some challenges that needed to be addressed in the final solution:
The solution was required to be modern, intuitive, and scalable, aligning with Novartis' long-term technical capabilities while addressing these user pain points.
To ensure the new SOP document search platform addressed both user expectations and technical constraints, I led an in-depth research process divided into two key phases:
We began with an expert usability review based on Jakob Nielsen’s 10 Usability Heuristics to identify major pain points in the existing system. This review helped highlight issues with navigation, visibility of system status, and inefficient feedback mechanisms.

Key findings from the expert usability review
I conducted 17 in-depth user interviews and led usability tests. These sessions were based on the existing Proof of Concept (PoC) and users' daily activities on the platform. Each session lasted approximately 75 minutes, and we gathered both qualitative and quantitative data.

Interviews affinity mapping
Key insights included:
This phase of research ensured that the final solution would be data-driven and human-centered, addressing specific pain points uncovered during testing.
To ensure alignment between user needs, technical constraints, and business objectives, I facilitated multiple cross-functional workshops. These sessions brought together stakeholders from product, development, and end-user teams to gather feedback, validate early concepts, and ensure that all teams were in sync throughout the design process.
We began with low-fidelity wireframes, prioritizing a user-friendly interface that made essential features more accessible and intuitive.
Key improvements included:
Once these wireframes were validated, we transitioned to interactive prototypes using Figma, which allowed for more dynamic user interactions and iterative feedback collection.
Usability testing was a continuous, iterative process. Through multiple testing rounds, we gathered actionable feedback that directly informed design improvements. For instance, when users indicated that the advanced search panel was too visually prominent, we adjusted its placement to reduce clutter without sacrificing its utility.
Each iteration focused on enhancing usability while balancing the platform’s functionality and technical requirements.


The final solution successfully addressed the main challenges uncovered through research, providing an intuitive, scalable platform aligned with Novartis’ technical capabilities.
Key elements of the solution included:
The revamped platform delivered measurable improvements in both usability and user satisfaction. Post-launch feedback and metrics highlighted the success of the design: